News

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs ...
A link to the live and archived webcasts may be accessed on the Unicycive website under the Investors section: Events and ...
This programme focuses on applied aspects of advanced and emerging analytical technologies to address current issues in food safety, nutrition and food supply. It covers the entire food chain from ...
Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to stopping aging ...
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) (“Unicycive” or the “Company”), a clinical stage biotechnology company developing ...
Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...
Bellarmine will visit Valley Christian for WCAL tournament title on Thursday. Los Altos’ Sly Cash pitches no-hitter against ...
New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with PDUFA target action date of June 28, 2025; ongoing ...
New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with ...
The partner of Theranos founder Elizabeth Holmes has raised millions of dollars for an artificial intelligence startup hoping to introduce a product that can be used in medical testing and other ...
Holmes' support for her partner's foray into biotech is striking, given she is serving a federal prison sentence for fraud in that same field. Over the course of her nearly four-month criminal ...
Holmes' support for her partner's foray into biotech is striking, given she is serving a federal prison sentence for fraud in that same field. Over the course of her nearly four-month criminal trial, ...